Prospective study of safety and efficacy of additional cryoablation after radiation therapy for malignant lung tumors

Prospective study of safety and efficacy of additional cryoablation after radiation therapy for malignant lung tumors - Prospective study of cryoablation after radiation therapy for malignant lung tumors

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018573

Enrollment

100

Registered

2015-08-06

Start date

2015-08-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary lung cancer, metastatic lung cancer

Interventions

Cryoablation is conducted after radiotherapy for malignant lung tumors larger than 2cm.Study duration is from July 2015 to March 2020.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Malignant lung tumors larger than 2cm.

Exclusion criteria

Exclusion criteria: Patients who are not torelable for radiotherapy and cryoablation therapy.

Design outcomes

Primary

Measure	Time frame
Side effect and local control rate by cryoablation after radiotherapy for malignant lung tumors	—

Countries

Japan

Contacts

Public ContactHarue Tachibana

Kameda Medical Center Review Board of Clinical Research

clinical_research@kameda.jp04-7092-2211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026